Mounjaro Atlanta
Mounjaro Atlanta
Trades under a brand-drug domain name while selling compounded tirzepatide
- Membership
- from $295/mo
- Medication
- Included
Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure
Zepbound Atlanta
Zepbound Atlanta publishes $395 for a first six weeks or $495 for a first eight weeks, with a footnote stating the product is patient-specific compounded weekly injectable tirzepatide rather than the branded Zepbound the domain refers to.
Sources captured · researched by Tom
As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.
Zepbound Atlanta publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers
These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.
Captured . Pages change — check the current version before relying on anything here.
Mounjaro Atlanta
Trades under a brand-drug domain name while selling compounded tirzepatide
Emerge
Compounded tirzepatide priced openly by dose, with the escalation cost shown up front
Willow
All-inclusive compounded plans with the FDA disclosure stated plainly